Alaunos Therapeutics (TCRT) traded down -25 % during a 24 hours period ending at 11:57 PM Central Europe on Monday 26th. One Alaunos Therapeutics stock can currently be bought for about USD 2.13 on popular exchanges. Current supply of Alaunos Therapeutics stocks is 3.4 mn. Alaunos Therapeutics has a current market capitalization of USD 7.8 mn and approximately USD 3 mn worth of Alaunos Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Alaunos Therapeutics has traded 101.77 % up. Simple moving average of last 200 days is at USD 2.36. The highest price of past 52 weeks was recorded at USD 4.5 on 12/12/2025. 52 weeks low was at USD 0.72 on 10/07/2026.
Here is how related stocks have performed in the past 24 hours:
Nextnrg (NXXT) traded up 1.67 % and now trades at USD 0.51. Nextnrg has a market capitalisation of USD 9.3 mn.
Palatin (PTN) traded down -7.26 % and now trades at USD 4.82. Current market capitalisation for Palatin is USD 9.1 mn.
Bullfrog Ai (BFRG) traded up 0.2 % and now trades at USD 0.48. Bullfrog Ai has a market capitalisation of USD 9.2 mn.
Ensysce Biosciences (ENSC) traded down -7.83 % and now trades at USD 0.45. Ensysce Biosciences has a market capitalisation of USD 9.2 mn.
Biovie (BIVI) traded down -3.12 % and now trades at USD 1.33. Biovie has a market capitalisation of USD 9.4 mn.
About Alaunos Therapeutics
Alaunos Therapeutics Inc. is a clinical stage cellular immuno-oncology company based in Houston, Texas, United States. The company specializes in the treatment of solid tumors through adoptive TCR-T cell therapy. As a biotechnology industry leader, Alaunos Therapeutics serves customers worldwide with the website www.alaunos.com and trades on the Nasdaq stock exchange.
